ERAS
Companies
NASDAQ
Erasca Inc.
Health Care
$1.40
-$1.11 (-44.22%)
Price Chart
Overview
About ERAS
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.
Market Cap
$647.9M
Volume
1.8M
Avg. Volume
2.1M
P/E Ratio
-1.6289189
Dividend Yield
0.00%
Employees
130.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.89
Moderate Correlation
Volatility
High (0.71)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ERAS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$647.9M
Volume1.8M
P/E Ratio-1.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025